<DOC>
	<DOCNO>NCT00333060</DOCNO>
	<brief_summary>The purpose trial compare ability two dose OT-551 ophthalmic solution drug-free solution safely effectively prevent delay progression nuclear cataract frequently develop result vitrectomy ( surgery retina repair ) , thereby avoid need second surgery ( cataract removal ) . Victrectomies involve removal jelly-like substance ( vitreous ) locate cavity behind lens .</brief_summary>
	<brief_title>Study OT-551 Eye Drops Prevent Delay Progression Nuclear Cataracts Following Vitreous Removal</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Retinal Perforations</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Imminent vitrectomy repair macular hole pucker Ability screen eligibility begin dose 710 day advance surgery Best correct ETDRS visual acuity equivalent Snellen 20/400 well surgical eye 20/100 good fellow eye Artificial lens lens surgical eye Cataract ( great slight opacity thickness ) surgical eye Any retinal abnormality may visionthreatening Serious heart , kidney , liver disease Recent ophthalmic surgery ( within 6 month ) ocular infection ( within 30 day ) Poorly control diabetes unstable glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>